Özlem Türeci

Özlem Türeci

scientist Germany

Özlem Türeci is a prominent Turkish-German physician and entrepreneur, best known as a co-founder of BioNTech, a biotechnology company that gained international acclaim for developing one of the first effective COVID-19 vaccines using mRNA technology. Türeci, along with her husband Ugur Sahin, has been instrumental in advancing innovative therapies for cancer, leveraging the same mRNA technology to enhance the immune system's ability to fight cancer cells. Recently, she was in the news due to a significant partnership between BioNTech and Bristol Myers Squibb to develop and commercialize a new cancer drug aimed at enhancing immune responses against tumors, reflecting her ongoing contributions to both cancer research and immunotherapy.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Germany Germany: Özlem Türeci is one of the founders of Biontech, which was recently awarded the Deutscher Nationalpreis 2025. 9

Süddeutsche Zeitung: Biontech: Vorbild für die deutsche Industrie - Wirtschaft

Germany Germany: Özlem Türeci is one of the founders of Biontech who received the Nationalpreis for their entrepreneurial and scientific achievements. 9

Süddeutsche Zeitung: Nationalpreis: Merz hält Laudatio für Biontech-Gründer Türeci und Şahin - Wirtschaft

Turkey Turkey: Özlem Türeci is a co-founder of the German company BioNTech, which is collaborating with Bristol Myers Squibb on cancer drug development. 9

Hürriyet: Kanser ilacı için dev ortaklık